Ocular Therapeutix™ Provides Fourth Quarter and Year-End 2022 Results and Corporate Update
March 06, 2023
Ocular Therapeutix™ to Present at Cowen’s 43rd Annual Healthcare Conference
February 28, 2023
Ocular Therapeutix™ To Report Fourth Quarter and Year-End 2022 Financial Results
February 21, 2023
Ocular Therapeutix™ Announces Interim 10-month Data from the Ongoing U.S. Phase 1 Clinical Trial Evaluating OTX-TKI for the Treatment of Wet AMD
February 11, 2023
Ocular Therapeutix™ Provides 2022 Year End Corporate Update and Reviews Expected 2023 Milestones
January 06, 2023